n Cardiovascular Journal of South Africa - Improvement in small artery function in type 2 diabetes following candesartan cilexitil treatment : drug trends in cardiology
|Article Title||Improvement in small artery function in type 2 diabetes following candesartan cilexitil treatment : drug trends in cardiology|
|© Publisher:||Clinics Cardive Publishing|
|Journal||Cardiovascular Journal of South Africa|
|Publication Date||May 2005|
Extracted from text ... Improvement in small artery function in type 2 diabetes following candesartan cilexitil treatment A recent trial of angiotensin II receptor blockade on vessel function, measured by pressure myography, has shown that even brief treatment (12 weeks) with candesartan cilexitil (Atacand) is associated with a significant improvement in resistance vessel endothelial function.1 This randomised, double-blind, placebo- controlled, parallel study was performed in 32 patients with type 2 diabetes, with and without hypertension. Patients were randomised to placebo or candesartan 8 mg daily for four weeks, which was then increased to 16 mg daily in all patients. Small arteries 63 to 230 ?m ..
Article metrics loading...